Post-operative Radiotherapy in Non-Small-Cell Lung Cancer: More Questions Than Answers
Author Information
Author(s): H Bartelink, J Jassem
Primary Institution: The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis
Hypothesis
The value of post-operative radiotherapy as an adjuvant to surgery for patients with non-small-cell lung cancer remains unproven.
Conclusion
The study indicates that while there is an improvement in local control, the trial lacks the statistical power to confirm a survival benefit.
Supporting Evidence
- An improvement in time to local recurrence and distant metastases was observed in N2 patients.
- Only 36% of patients allocated to radiotherapy received the treatment as specified in the protocol.
- A larger trial is needed to adequately assess the effect of post-operative radiotherapy on survival.
Takeaway
Doctors are trying to find out if giving radiation after lung cancer surgery helps patients live longer, but they need more patients in their studies to be sure.
Methodology
The study involved a small randomized trial with a limited number of patients and low radiation doses.
Limitations
The trial had a small sample size, low radiation doses, many ineligible patients, inappropriate staging, and no quality assurance.
Participant Demographics
Patients with non-small-cell lung cancer, specifically N2 patients.
Want to read the original?
Access the complete publication on the publisher's website